1,798
Views
3
CrossRef citations to date
0
Altmetric
Neurology

The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis

, , , , , & show all
Pages 479-486 | Received 11 Jan 2021, Accepted 08 Mar 2021, Published online: 13 Apr 2021

Figures & data

Figure 1. Study population identified from the Workpartners Research Reference Database (RRDb).

Figure 1. Study population identified from the Workpartners Research Reference Database (RRDb).

Figure 2. Optimal and suboptimal year-1 outcomes among employees with MS treated with DMTs.

Figure 2. Optimal and suboptimal year-1 outcomes among employees with MS treated with DMTs.

Table 1. Baseline demographic characteristics for employees with MS with and without suboptimal year-1 outcomes.

Table 2. Baseline clinical characteristics for employees with MS with and without suboptimal year-1 outcomes.

Figure 3. Direct and indirect costs ($) for employees with and without suboptimal year-1 outcomes.

Figure 3. Direct and indirect costs ($) for employees with and without suboptimal year-1 outcomes.
Supplemental material

Supplemental Material

Download ()

Data availability statement

The data utilized for this study were obtained through a license agreement with Workpartners.